reading sequence threads from 2024 and half of it aged badly
sequence. That is the whole post, but I will justify it. Everything else people worry about in c/glp1science is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort sequence out first, and almost nobody does. I say this having got it wrong for 20 months. My…
the sequence variation is the real issue
This is the "correlation is mechanism" thing again. You changed three variables at once.
BPC pentadecapeptide is a naming problem, three things are called this
near-zero controlled human data, full stop
The fatigue was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
the sequence variation is the real issue
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.